αααααβααΎαMNKD β’ NASDAQ
add
MannKind Corp
5.49$
26 ααααΆ, 10:06:34 AM ααααβααα -5 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
5.46$
α
αααααααααααα
5.43$ - 5.55$
α
ααααααα½αααααΆαα
α»αααααα
3.38$ - 6.51$
ααΎαβαα»αβααΈααααΆα
1.70Β αααΈααΆα USD
ααα ααα½αααΌαααααα
3.89Β ααΆα
α’αα»ααΆα P/E
59.25
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 82.13Β ααΆα | 17.20% |
α
αααΆαααααα·ααααα·ααΆα | 43.15Β ααΆα | 17.12% |
α
αααΌααα»ααα | 7.98Β ααΆα | -30.87% |
ααααΆααα
αααααα»ααα | 9.72 | -41.02% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.07 | 75.00% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 20.84Β ααΆα | 20.22% |
α’ααααΆαααααααααΆαααααα·αααααΆα | -2.62% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 260.04Β ααΆα | 0.99% |
ααααααααα»α | 494.64Β ααΆα | 6.56% |
ααΆαααα½ααα»αααααΌαααα»α | 539.19Β ααΆα | -20.02% |
ααΌαβααααα»α | -44.55Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 307.07Β ααΆα | β |
ααααααααααΉαααααα
| -36.40 | β |
ααα
ααααααΎαααααα | 10.36% | β |
ααα
ααααααΎααΎααα»α | 33.72% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 7.98Β ααΆα | -30.87% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 23.64Β ααΆα | 153.35% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -25.06Β ααΆα | 39.26% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 71.81Β ααΆα | 3,166.01% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 70.39Β ααΆα | 305.41% |
ααα αΌαααΆα
αααααΆααααααα | 5.24Β ααΆα | 0.80% |
α’αααΈ
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
ααΆααααααΎαα‘αΎα
αα»αααα 1991
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
405
